Oncternal Therapeutics Inc (ONCT) USD0.001
Sell:$8.00Buy:$9.01
$0.22 (2.51%)
- This stock can be held in a
Stocks and Shares ISASell:$8.00
Buy:$9.01
Change:$0.22 (2.51%)
$0.22 (2.51%)Prices delayed by at least 15 minutes
Sell:$8.00
Buy:$9.01
Change:$0.22 (2.51%)
$0.22 (2.51%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 8 April 2024 | Robert James WillsDirector | Buy Regular purchase transaction | 3,086 | $8.96 | $27,654.57 | 10,000 |
| 28 March 2024 | Robert James WillsDirector | Buy Regular purchase transaction | 6,914 | $8.48 | $58,602.37 | 6,914 |
| 23 February 2024 | David F HaleChairman of the Board | Buy Regular purchase transaction | 266 | $9.04 | $2,404.64 | 29,673 |
| 23 February 2024 | David F HaleChairman of the Board | Buy Regular purchase transaction | 714 | $9.04 | $6,454.56 | 714 |
| 23 February 2024 | Robert James WillsDirector | Sell Regular sell transaction (market) | 980 | $9.04 | $8,859.20 | 0 |
| 3 January 2024 | James B. BreitmeyerPresident/CEO | Sell Tax related | 50,955 | $0.50 | $25,278.78 | 443,034 |
| 3 January 2024 | Richard G VincentCFO | Sell Tax related | 8,868 | $0.50 | $4,399.41 | 140,922 |
| 3 January 2024 | Salim YazjiOther Level A | Sell Tax related | 19,742 | $0.50 | $9,794.01 | 128,635 |
| 3 January 2024 | Chase C LeavittGeneral Counsel | Sell Tax related | 11,838 | $0.50 | $5,872.83 | 84,758 |
| 3 January 2024 | Rajesh KrishnanCTO | Sell Tax related | 11,838 | $0.50 | $5,872.83 | 44,019 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 28 March 2024 | Robert James WillsDirector | Buy Regular purchase transaction | 6,914 | $8.48 | $58,602.37 | 6,914 |
| 8 April 2024 | Robert James WillsDirector | Buy Regular purchase transaction | 3,086 | $8.96 | $27,654.57 | 10,000 |
| 3 January 2024 | James B. BreitmeyerPresident/CEO | Sell Tax related | 50,955 | $0.50 | $25,278.78 | 443,034 |
| 3 July 2023 | James B. BreitmeyerPresident/CEO | Sell Tax related | 47,992 | $0.36 | $17,277.12 | 493,989 |
| 3 January 2024 | Salim YazjiOther Level A | Sell Tax related | 19,742 | $0.50 | $9,794.01 | 128,635 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.